Adam R. Craig, President and CEO at CTI BIOPHARMA CORP (CTIC), sold 85,317 shares at $6.00 ($512K) on 2023-01-24, disclosed to the SEC on 2023-01-26.
Open-market sale of $512k CTIC by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.00 | 83,200 | $499K | 97.5% |
| 2 | $6.01 | 2,117 | $13K | 2.5% |
| Total | $6.00 avg | 85,317 | $512K | 100% |
| Filing → |
| CTIC | SELL | 2023-01-03 | $1.2M | — | Filing → |
| CTIC | SELL | 2022-11-14 | $1.6M | — | Filing → |
| CTIC | SELL | 2022-09-14 | $1.6M | — | Filing → |